Figure 5

Predicted minimum inhibitory concentration (MIC, µg/mL) and corresponding 95% confidence intervals for E. coli accelerated failure time (AFT) models for each antimicrobial drug model, by therapeutic spectinomycin treatment status. Dashed lines mark resistant breakpoints based on CLSI criteria for each antimicrobial drug.